advanced adult primary liver cancer
Showing 1 - 25 of >10,000
Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT
Active, not recruiting
- Advanced Adult Primary Liver Cancer
- +3 more
- positron emission tomography
- computed tomography
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Nov 9, 2022
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Metastatic Extrahepatic Bile Duct Cancer Trial in
Active, not recruiting
- Adult Primary Hepatocellular Carcinoma
- +6 more
- PET scan
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 21, 2022
Adult Primary Liver Cancer, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer Trial in
Recruiting
- Adult Primary Liver Cancer
- +2 more
- TSR-022 and TSR-042
-
Honolulu, HawaiiUniversity of Hawaii
Sep 22, 2021
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Advanced Adult Hepatocellular Carcinoma Trial in
Completed
- Adult Primary Hepatocellular Carcinoma
- +4 more
- Chinese herbal formulation PHY906
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 26, 2021
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer Trial in
Active, not recruiting
- Adult Primary Hepatocellular Carcinoma
- +2 more
- sorafenib tosylate
- stereotactic body radiation therapy
-
Berkeley, California
- +50 more
Nov 17, 2022
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer
Recruiting
- Adult Primary Hepatocellular Carcinoma
- +3 more
- yttrium Y 90 glass microspheres
- laboratory biomarker analysis
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Sep 17, 2020
Non-alcoholic Fatty Liver Disease (NAFLD), Alcoholic Liver Disease (ALD), Liver Fibrosis Trial in France (eLIFT)
Not yet recruiting
- Non-alcoholic Fatty Liver Disease (NAFLD)
- +2 more
- eLIFT
-
Angers, France
- +5 more
Jan 26, 2023
Advanced Liver Fibrosis Using Non-invasive Tests in Primary Care
Not yet recruiting
- Hepatic Fibrosis
- (no location specified)
Oct 31, 2023
Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Tumor Trial in Los Angeles (Biospecimen
Recruiting
- Advanced Cholangiocarcinoma
- +6 more
- Biospecimen Collection
- +3 more
-
Los Angeles, California
- +1 more
Mar 31, 2023
Primary Liver Cancer Early Detection
Recruiting
- Liver Cancer
- Liver-cancer early detection test
-
Changchun, Jilin, China
- +1 more
Aug 10, 2023
Advanced Hepatocellular Carcinoma (HCC), Gastric Cancer Metastatic to Liver, Colorectal Cancer Metastatic to Liver Trial in
Recruiting
- Advanced Hepatocellular Carcinoma (HCC)
- +2 more
-
Duarte, California
- +2 more
Aug 29, 2022
Advanced Primary Liver Cancer Trial (IBR900 combined with Lenvatinib, IBR900 combined with Bevacizumab)
Not yet recruiting
- Advanced Primary Liver Cancer
- IBR900 combined with Lenvatinib
- IBR900 combined with Bevacizumab
- (no location specified)
Jun 6, 2022
Colon Cancer Liver Metastases Trial (sequential adult left lateral lobe liver transplantation (SALT))
Not yet recruiting
- Colon Cancer Liver Metastases
- sequential adult left lateral lobe liver transplantation (SALT)
- (no location specified)
Oct 3, 2023
Liver Cancer Trial in Wuhan (Autologous Tumor Infiltrating Lymphocytes)
Recruiting
- Liver Cancer
- Autologous Tumor Infiltrating Lymphocytes
-
Wuhan, ChinaTongji Hospital
Oct 9, 2023
Primary Biliary Cholangitis (PBC) Trial (Elafibranor, Matched 80 mg )
Not yet recruiting
- Primary Biliary Cholangitis (PBC)
- Elafibranor
- Matched 80 mg placebo
- (no location specified)
Aug 29, 2023
A Study of Pancreatic Cancer in Xenografts From Liver Metastases
Completed
- Pancreatic Cancer
- +3 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
Liver Transplant Disorder, Hepatic Cancer Trial (assisted liver transplantation combined with two-stage hepatectomy)
Not yet recruiting
- Liver Transplant Disorder
- Hepatic Cancer
- assisted liver transplantation combined with two-stage hepatectomy
- (no location specified)
Mar 6, 2023
Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Tumor Trial in Duarte (ECT204 T cells)
Recruiting
- Hepatocellular Carcinoma
- +3 more
- ECT204 T cells
-
Duarte, California
- +1 more
Jan 9, 2023
Liver, Cancer of, Primary Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)
Recruiting
- Liver, Cancer of, Primary Resectable
- Oxaliplatin
- +5 more
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Jan 18, 2023
Adult Primary Hepatocellular Carcinoma, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary
Suspended
- Adult Primary Hepatocellular Carcinoma
- +3 more
- sorafenib tosylate
- +2 more
-
Birmingham, Alabama
- +20 more
Aug 29, 2022
Hepatocellular Carcinoma Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)
Recruiting
- Hepatocellular Carcinoma Resectable
- Oxaliplatin
- +5 more
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Mar 1, 2023
Colorectal Tumors Trial in Hangzhou (Resin microspheres containing yttrium-90 (Y-90))
Not yet recruiting
- Colorectal Neoplasms
- Resin microspheres containing yttrium-90 (Y-90)
-
Hangzhou, Zhejiang, ChinaSir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang
Oct 11, 2023
Advanced Rectal Cancer, Liver Metastasis, Pulmonary Metastasis Trial in Shanghai (a combination therapy)
Not yet recruiting
- Advanced Rectal Cancer
- +3 more
- a combination therapy including tislelizumab
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 9, 2022
Primary Liver Cancer Trial in Shanghai (Embosphere and chemo drug, Polyvinyl alcohol embolization microspheres (Huihe Medical)
Enrolling by invitation
- Primary Liver Cancer
- Embosphere and chemotherapy drug
- Polyvinyl alcohol embolization microspheres (Huihe Medical) and chemotherapy drug
-
Shanghai, Shanghai, ChinaShanghai Huihe Healthcare Tecnology Co.,Ltd.
Mar 5, 2023